Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

Current perspectives on HIV-1 antiretroviral drug resistance.

Iyidogan P, Anderson KS.

Viruses. 2014 Oct 24;6(10):4095-139. doi: 10.3390/v6104095. Review.

2.

Burden of nonnucleoside reverse transcriptase inhibitor resistance in HIV-1-infected patients: a systematic review and meta-analysis.

Snedecor SJ, Sudharshan L, Nedrow K, Bhanegaonkar A, Simpson KN, Haider S, Chambers R, Craig C, Stephens J.

AIDS Res Hum Retroviruses. 2014 Aug;30(8):753-68. doi: 10.1089/AID.2013.0262. Epub 2014 Jul 8. Review.

3.

The Need for Development of New HIV-1 Reverse Transcriptase and Integrase Inhibitors in the Aftermath of Antiviral Drug Resistance.

Wainberg MA.

Scientifica (Cairo). 2012;2012:238278. doi: 10.6064/2012/238278. Epub 2012 Dec 31. Review.

4.

Molecular mechanism of antagonism between the Y181C and E138K mutations in HIV-1 reverse transcriptase.

Xu HT, Oliveira M, Asahchop EL, McCallum M, Quashie PK, Han Y, Quan Y, Wainberg MA.

J Virol. 2012 Dec;86(23):12983-90. doi: 10.1128/JVI.02005-12. Epub 2012 Sep 19.

5.

Connection domain mutations during antiretroviral treatment failure in Mali: frequencies and impact on reverse transcriptase inhibitor activity.

Maiga AI, Penugonda S, Katile D, Diallo F, Fofana DB, Berzins B, Maiga MY, Sylla A, Traore HA, Marcelin AG, Calvez V, Tounkara A, Bellosillo N, Murphy R, Taiwo B.

J Acquir Immune Defic Syndr. 2012 Nov 1;61(3):293-6. doi: 10.1097/QAI.0b013e31826a4b34.

6.

Impact of the N348I mutation in HIV-1 reverse transcriptase on nonnucleoside reverse transcriptase inhibitor resistance in non-subtype B HIV-1.

McCormick AL, Parry CM, Crombe A, Goodall RL, Gupta RK, Kaleebu P, Kityo C, Chirara M, Towers GJ, Pillay D.

Antimicrob Agents Chemother. 2011 Apr;55(4):1806-9. doi: 10.1128/AAC.01197-10. Epub 2011 Jan 31.

7.

Characterization of the E138K resistance mutation in HIV-1 reverse transcriptase conferring susceptibility to etravirine in B and non-B HIV-1 subtypes.

Asahchop EL, Oliveira M, Wainberg MA, Brenner BG, Moisi D, Toni Td, Tremblay CL.

Antimicrob Agents Chemother. 2011 Feb;55(2):600-7. doi: 10.1128/AAC.01192-10. Epub 2010 Dec 6.

8.

Constrained patterns of covariation and clustering of HIV-1 non-nucleoside reverse transcriptase inhibitor resistance mutations.

Reuman EC, Rhee SY, Holmes SP, Shafer RW.

J Antimicrob Chemother. 2010 Jul;65(7):1477-85. doi: 10.1093/jac/dkq140. Epub 2010 May 12.

Supplemental Content

Support Center